Success Story: NIW Approved In Just 30 Days For A Bangladeshi Expert With Premium Processing Service and Our Strategic Filing
Client’s Testimonial:
"I am very satisfied with your service.”
On April 22nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for an Expert in the Field of Cell Biology (Approval Notice).
General Field: Cell Biology
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Illinois
Approval Notice Date: April 22nd, 2026
Processing Time: 30 days (Premium Processing Requested)
Case Summary:
We are pleased to share that we secured an I-140 NIW approval in just 30 days for a client whose petition was filed with direct Premium Processing. The client holds an M.S. in Cell and Developmental Biology and works in the field of cell biology, with a research focus on identifying molecular vulnerabilities that drive cancer progression and may support the development of targeted therapies.
The client’s proposed endeavor centered on studying regulatory factors that become dysregulated across specific cancer types. Rather than presenting this as general cancer research, the petition framed the work as part of precision oncology because it aims to clarify mechanisms of tumor progression and support clinically actionable therapeutic strategies.
To demonstrate that the client was well-positioned to advance this endeavor, we highlighted her record of 3 peer-reviewed journal articles, including 1 first-authored article and 1 co-first-authored article, along with 2 abstracts. We also noted that her work had appeared in respected publication venues.
The client had also completed 1 peer review. While modest in number, this evidence still supported the argument that her expertise had begun to be recognized by the broader research community.
A particularly important part of the petition was the evidence that the client’s research had been supported by funding from the National Institutes of Health and the National Science Foundation. We used this evidence carefully, not as a personal award claim, but as confirmation that the research direction aligned with federally supported priorities in health, biotechnology, and scientific discovery.
The petition also included 1 letter of recommendation from an expert in the field. This letter helped explain the importance of the client’s work, her technical skillset, and why her continued research would benefit the United States.
We congratulate our client on this swift I-140 NIW approval in 30 days and wish her continued success in advancing cancer research and targeted therapeutic development in the United States.